In March 2025, the company announced new programs for just a immediate-to-buyer giving of its Wegovy weight loss drug. The company proven a brand new pharmacy, referred to as NovoCare, which would charge customers $499 every month for use of the drug, less than 50 % the price of the drug via other pharmaceutical distribution networks.[fifty three]t